CN106811548B - Slc38a4作为结肠腺癌的诊治靶标 - Google Patents
Slc38a4作为结肠腺癌的诊治靶标 Download PDFInfo
- Publication number
- CN106811548B CN106811548B CN201710233329.6A CN201710233329A CN106811548B CN 106811548 B CN106811548 B CN 106811548B CN 201710233329 A CN201710233329 A CN 201710233329A CN 106811548 B CN106811548 B CN 106811548B
- Authority
- CN
- China
- Prior art keywords
- slc38a4
- gene
- protein
- colon adenocarcinoma
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710233329.6A CN106811548B (zh) | 2017-04-11 | 2017-04-11 | Slc38a4作为结肠腺癌的诊治靶标 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710233329.6A CN106811548B (zh) | 2017-04-11 | 2017-04-11 | Slc38a4作为结肠腺癌的诊治靶标 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106811548A CN106811548A (zh) | 2017-06-09 |
CN106811548B true CN106811548B (zh) | 2020-06-16 |
Family
ID=59115947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710233329.6A Active CN106811548B (zh) | 2017-04-11 | 2017-04-11 | Slc38a4作为结肠腺癌的诊治靶标 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106811548B (zh) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011149859A (ja) * | 2010-01-22 | 2011-08-04 | Igaku Seibutsugaku Kenkyusho:Kk | 食道癌マーカー |
-
2017
- 2017-04-11 CN CN201710233329.6A patent/CN106811548B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN106811548A (zh) | 2017-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2008251381B2 (en) | Biomarkers for melanoma | |
CN105980576B (zh) | 用于源自乳腺癌的骨转移癌的预后和治疗的方法 | |
US20140221244A1 (en) | Methods and Compositions for the Treatment and Diagnosis of Colorectal Cancer | |
US20140323342A1 (en) | Methods and Compositions for the Treatment and Diagnosis of Bladder Cancer | |
US20140235486A1 (en) | Methods and Compositions for the Treatment and Diagnosis of Breast Cancer | |
WO2013052480A1 (en) | Marker-based prognostic risk score in colon cancer | |
WO2013025322A2 (en) | Marker-based prognostic risk score in liver cancer | |
US20140315743A1 (en) | Methods and Compositions for the Treatment and Diagnosis of Ovarian Cancer | |
CN112626207B (zh) | 一种用于区分非侵袭性和侵袭性无功能垂体腺瘤的基因组合 | |
JP5858405B2 (ja) | 肺腺がんの予後予測方法、および、肺腺がんの検出キット | |
CN106947818B (zh) | 一种诊治结肠腺癌的分子标志物 | |
WO2019134994A1 (en) | Prognostic biomarkers for human papillomavirus positive cancers | |
CN107022635B (zh) | Acadl基因及其表达产物在制备腹主动脉瘤诊治产品中的应用 | |
CN106811532B (zh) | Acta1作为舌鳞癌诊治标志物的用途 | |
CN106811548B (zh) | Slc38a4作为结肠腺癌的诊治靶标 | |
AU2018244758A1 (en) | Method and kit for diagnosing early stage pancreatic cancer | |
CN106947819B (zh) | 结肠腺癌诊治标志物 | |
CN106947820B (zh) | Vcan在结肠腺癌诊治中的用途 | |
CN106834496B (zh) | Pnliprp3基因及其表达产物在舌鳞癌诊治中的应用 | |
CN106893778B (zh) | 一种诊治舌鳞癌的分子标志物 | |
CN106947821B (zh) | 用于诊治结肠腺癌的生物标志物 | |
CN106906286B (zh) | 用于诊治舌鳞癌的基因标志物 | |
KR101346038B1 (ko) | 간암 예후 예측용 조성물 또는 키트, 및 간암 예후 예측 방법 | |
CN107385098B (zh) | 胃腺癌转移诊治工具 | |
CN107385096B (zh) | Lrrtm1基因及其表达产物在制备胃腺癌转移诊治工具中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181102 Address after: 610015 2 buildings 8, 9, 10, 14 and 17, 219 Tianfu Third Street, Chengdu high tech Zone, Sichuan Applicant after: Chengdu Wang Lu Medicine Technology Co., Ltd. Address before: 100080 room 3103, cube court building, 1 good luck street, Haidian District, Beijing. Applicant before: Beijing Yang Shen biology information technology company limited |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210415 Address after: 266000 room 2503, Qianshan building, D2, Qingdao International Innovation Park Phase II, No.1 Keyuan Weiyi Road, Laoshan District, Qingdao City, Shandong Province Patentee after: Qingdao Yangshen biomedical Co.,Ltd. Address before: 610015 2 buildings 8, 9, 10, 14 and 17, 219 Tianfu Third Street, Chengdu high tech Zone, Sichuan Patentee before: Chengdu Wang Lu Medicine Technology Co.,Ltd. |